HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study

Clinical trial NCT07215468 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07215468
Sponsor: TaiMed Biologics Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HIV -1 Infection

Start date: 2025-12-16
Primary completion: 2027-05-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.